Page last updated: 2024-09-04

4-methoxyhonokiol and Cancer of Prostate

4-methoxyhonokiol has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, BW; Ban, JO; Ham, YW; Han, SB; Hong, JT; Jung, JK; Lee, HP; Lee, NJ; Oh, JH; Shim, JH; Yoon, DY	1

Other Studies

1 other study(ies) available for 4-methoxyhonokiol and Cancer of Prostate

Article	Year
4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-κB activity. British journal of pharmacology, 2013, Volume: 168, Issue:5 Topics: Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Humans; Lignans; Male; Mice; Mice, Nude; NF-kappa B; PPAR gamma; Prostatic Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays	2013

Article

Year

4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-κB activity.

British journal of pharmacology, 2013, Volume: 168, Issue:5

Topics: Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Humans; Lignans; Male; Mice; Mice, Nude; NF-kappa B; PPAR gamma; Prostatic Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays

2013